American Society of Clinical Oncology (ASCO) 2019 Annual Meeting Jun 12019 1:15 PM CDT Jun 1, 2019 | 1:15 PM CDT Supporting Materials Phase 2 Cemiplimab in locally advanced CSCC – primary analysis 2 MB Phase 1 of REGN3767 (LAG-3) and Cemiplimab 2.3 MB Phase 2 Cemiplimab in metastatic CSCC – 12-month follow-up 348.4 KB
Phase 2 Cemiplimab in locally advanced CSCC – primary analysis 2 MB Phase 1 of REGN3767 (LAG-3) and Cemiplimab 2.3 MB Phase 2 Cemiplimab in metastatic CSCC – 12-month follow-up 348.4 KB